BioNeutral Announces Major Sales Milestone Achievement
April 17 2014 - 7:45AM
Marketwired
BioNeutral Announces Major Sales Milestone Achievement
NEWARK, NJ--(Marketwired - Apr 17, 2014) - BioNeutral Group,
Inc. (OTCBB: BONU) (OTCQB: BONU), today announced that Quip
Laboratories (Quip) has made great strides in the ever important
product launch process of BioNeutral products for the market
segments of laboratory animal research and biomedical research.
Quip Laboratories a leader in sales distribution of cleaning and
disinfection solutions to the life science marketplace since 1981
has completed two major elements to its 2014 commercialization
strategy of the BioNeutral products. First, YGIENE 206 and OGIENE
Odor Eliminator product training was completed during the annual
"QUIP University" Sales meeting in March and second, QUIP has
featured YGIENE 206 in its recent market awareness campaign of
April 4, 2014.
The "QUIP University" Sales training was completed during the
week of March 17th. YGIENE 206 and OGIENE Odor Eliminator product
training was conducted by the QUIP marketing team and guest faculty
members from BioNeutral. With all of QUIP's Sales professionals
fully trained, the BioNeutral products are obtaining broad exposure
to the Biomedical Research and Lab Animal Science markets
nationally. "The excitement level and depth of questions
surrounding BioNeutral's combinational chemistry during the
training was impressive," commented Dr. Andy Kielbania, Chief
Science Officer for BioNeutral. "It is clear that both YGIENE and
OGIENE will be introduced to this highly technical marketplace by
sales professionals that have the credibility and depth of
knowledge to do it right."
QUIP Laboratories featured the YGIENE 206 Sterilant/Disinfectant
in its recent "Biosafety Update" product awareness campaign on
April 4, 2014. QUIP is utilizing direct email to generate immediate
exposure and rapid interest, nationally, for YGIENE 206 as one of
its exciting new products for 2014.
"YGIENE 206 has already been enthusiastically received by our
clients in the Biomedical Research and Laboratory Animal Research
sectors," reports Nick Hidell, product manager for QUIP, "and we're
not surprised, given how well the product fits into our product
portfolio. The response, from both current and prospective clients,
to the product's consistent efficacy, ready-to-use accessibility
and long shelf-life, is exciting and indicates that we are
well-positioned to gain rapid share among clients in the market
sectors we serve." Hidell concluded by saying that, "we see this as
both a market disrupter, and game changer, in terms of client
acquisition across several sectors we're targeting for expansion in
2014."
About Quip Laboratories, Inc. Based in Wilmington, DE and
founded in 1981, Quip Laboratories focuses on providing sanitation
solutions to Life Science and Food Processing sectors. Their
state-of-the-art manufacturing facility produces proprietary
chemicals that have enabled the company to achieve a leadership
position in the markets served. Featuring in-house research and
development, production, quality control and sales and marketing,
Quip provides a "total-systems" approach to providing efficient and
eco-gentle environment hygiene. Find Quip at www.quiplabs.com.
About BioNeutral Group, Inc. Headquartered in Newark, New
Jersey, BioNeutral Group, Inc., is a specialty technology-based
life-science company that has developed a technology platform that
neutralizes harmful environmental contaminants, toxins and
dangerous micro-organisms including bacteria, viruses, mold, fungi
and spores. BioNeutral's products, YGIENE™ and OGIENE™, kill germs
and clean surfaces with a dramatic increase in speed and power over
their rivals in the marketplace. BioNeutral's proprietary platform
technology has been proven effective in surface, water and airborne
applications. Its antimicrobial line of products under the YGIENE™
brand have been approved by the EPA for sale in the United States
and has previously been approved for sale in Germany and it is also
permitted to be sold in the UK, France and Sweden. For more
information on BioNeutral, including a listing of company products,
leadership and background please visit www.bioneutral.com.
Find us on Facebook:
http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
Forward-Looking Statements: This release contains
certain "forward-looking statements" relating to the business of
the Company and its subsidiary companies. These forward-looking
statements are often identified by the use of forward-looking
terminology such as "believes," "expects" or similar expressions.
Such forward-looking statements involve known and unknown risks and
uncertainties that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
described in the Company's filings with the Securities and Exchange
Commission. BioNeutral routinely tests its formulations against
those of its competitors. The results are published to let
shareholders know how the Company's technology compares with known
formulations in the market place. Any product claim for
antimicrobial activity requires approval from the EPA or FDA,
depending upon where and how the formulations are used. The EPA has
approved and registered the Company's data and findings specific to
YGIENE-206. BioNeutral's antimicrobial formulations will be
marketed under the brand name YGIENE™ and are available for sale in
the United States.
CONTACT FOR THE COMPANY: Mark Lowenthal CEO BioNeutral Group,
Inc. +1-973-577-8003